Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors
A phase 2 trial of Capecitabine, Cisplatin and Streptozocin in Pancreatic neuroendocrine tumours, run by Cambridge University Hospitals NHS Foundation Trust, completed.
Overview
Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors is a phase 2 interventional study registered as NCT00602082 by Cambridge University Hospitals NHS Foundation Trust, with 84 participants recorded, started 2005-08 and reaching its primary completion in 2009-12. Interventions recorded: capecitabine, cisplatin, streptozocin, DNA analysis, RNA analysis, protein analysis, proteomic profiling, laboratory biomarker analysis. Conditions recorded: Gastrointestinal Carcinoid Tumor, Islet Cell Tumor.
Linked to the drug Streptozocin because the registry names it among its interventions and Pancreatic neuroendocrine tumours among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialA Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)]
Shares Capecitabine, Cisplatin and the tag pipeline.
- TrialPhase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms
Shares Streptozocin and the tag pipeline.
- TrialStudy of Durvalumab Versus Placebo in Combination With Definitive Chemoradiation Therapy in Patient With ESCC
Shares Capecitabine, Cisplatin and the tag pipeline.
- TrialAn Open-label Phase 3 Study of Lutetium (177Lu) Oxodotreotide Injection in Subjects With Advanced Gastrointestinal Pancreatic Neuroendocrine Tumors.
Shares Pancreatic neuroendocrine tumours and the tag pipeline.
- TrialStudy of SHR-8068 Combined With Adebrelimab and Platinum-containing Chemotherapy in the Treatment of Advanced Gastric and Esophageal Cancer
Shares Capecitabine, Cisplatin and the tag pipeline.
- TrialA Phase Ⅲ Study of Hemay022 in Combination With AI In Advanced Breast Cancer
Shares Capecitabine and the tag pipeline.
- TrialA Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced, Recurrent, or Metastatic HR+/HER2- Breast Cancer After Failure of Prior Endocrine Therapy(PANKU-Breast03)
Shares Capecitabine and the tag pipeline.
- TrialA Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
Shares Capecitabine and the tag pipeline.